Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary J Kelloff

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
European Journal of Cancer (Oxford, England : 1990)|March 2, 2005
New science-based endpoints to accelerate oncology drug developmentGary J Kelloff, Caroline C Sigman
Nature Reviews. Drug Discovery|February 11, 2012
Cancer biomarkers: selecting the right drug for the right patientGary J Kelloff, Caroline C Sigman
Nature Reviews. Cancer|June 15, 2007
Assessing intraepithelial neoplasia and drug safety in cancer-preventive drug developmentGary J Kelloff, Caroline C Sigman
Mutation Research|August 9, 2005
Development of cancer chemopreventive drugs based on mechanistic approachesVernon E Steele, Gary J Kelloff
AJR. American Journal of Roentgenology|May 22, 2009
Challenges in clinical prostate cancer: role of imagingGary J Kelloff, Peter Choyke, Donald S Coffey, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 30, 2009
Early detection of oral neoplasia: watching with new eyesGary J Kelloff, Caroline C Sigman, Christopher H Contag
Urologic Oncology|March 10, 2015
Biomarker development in the context of urologic cancersGary J Kelloff, Caroline C Sigman, Howard I Scher
Radiology|November 21, 2007
Regulatory and reimbursement challenges for molecular imagingJohn M Hoffman, Sanjiv S Gambhir, Gary J Kelloff
Drug Discovery Today|July 12, 2008
Targeted imaging: an important biomarker for understanding disease progression in the era of personalized medicineWilliam C Eckelman, Richard C Reba, Gary J Kelloff
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2006
Imaging and oncologic drug developmentWafik S El-Deiry, Caroline C Sigman, Gary J Kelloff
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
European Journal of Cancer (Oxford, England : 1990)|March 2, 2005
New science-based endpoints to accelerate oncology drug developmentGary J Kelloff, Caroline C Sigman
Nature Reviews. Drug Discovery|February 11, 2012
Cancer biomarkers: selecting the right drug for the right patientGary J Kelloff, Caroline C Sigman
Nature Reviews. Cancer|June 15, 2007
Assessing intraepithelial neoplasia and drug safety in cancer-preventive drug developmentGary J Kelloff, Caroline C Sigman
Mutation Research|August 9, 2005
Development of cancer chemopreventive drugs based on mechanistic approachesVernon E Steele, Gary J Kelloff
AJR. American Journal of Roentgenology|May 22, 2009
Challenges in clinical prostate cancer: role of imagingGary J Kelloff, Peter Choyke, Donald S Coffey, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 30, 2009
Early detection of oral neoplasia: watching with new eyesGary J Kelloff, Caroline C Sigman, Christopher H Contag
Urologic Oncology|March 10, 2015
Biomarker development in the context of urologic cancersGary J Kelloff, Caroline C Sigman, Howard I Scher
Radiology|November 21, 2007
Regulatory and reimbursement challenges for molecular imagingJohn M Hoffman, Sanjiv S Gambhir, Gary J Kelloff
Drug Discovery Today|July 12, 2008
Targeted imaging: an important biomarker for understanding disease progression in the era of personalized medicineWilliam C Eckelman, Richard C Reba, Gary J Kelloff
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2006
Imaging and oncologic drug developmentWafik S El-Deiry, Caroline C Sigman, Gary J Kelloff
Pageof 5